Immedica’s vision is to become the leading and preferred rare disease and specialty care partner by launching and making niche specialty and rare disease medicines available to patients with high unmet medical need in Europe and the Middle East.

Our ESG strategy is closely linked to our overall business strategy. By bringing innovative treatments to patients, we are committed to improving the quality of lives for patients and their families which makes a huge difference to their daily lives.